Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us


Global Cushing’s Syndrome and Acromegaly Treatment Market to Thrive on the Back of Government’s Extended Support

Press release Description

Albany, New York, January 11, 2019: Cushing’s syndrome and Acromegaly Treatment Market has been experiencing a spur in the growth, with growing prevalence of these diseases across the globe. According to the Cushing’s Support & Research Foundation (CSRF), nearly 15 individuals per million are found to be affected from Cushing’s disease every year. Rise in geriatric population worldwide, which is more prone to various diseases, is another factor underpinning growth of the market. With the increasing health consciousness in the society, people are increasing their healthcare budgets to obtain better cure. However, the current relapse rate of this condition is approximately 15-20%.

Additionally, the governments across the world have extended their support for the treatment of this rare disease by giving it an orphan drug designation. Extensively, the governments are providing funds and tax exemption benefits to the healthcare institutions that are directly or indirectly involved in the research and development of the Cushing’s syndrome and Acromegaly Treatment. The Cushing’s syndrome and Acromegaly treatment market is anticipated to register over 9% CAGR through 2026.

These insights have been gleaned from a study titled, “Global Cushing’s Syndrome and Acromegaly Treatment Market: Rising Demand for Non Invasive Treatment Trending the Global Market”, in the repository of Market Research Report Search Engine (MRRSE).

North America remains a lucrative region for growth of the Cushing’s Syndrome and Acromegaly Treatment market, which can be attributed to the region’s robust healthcare infrastructure along with excellent reimbursement to medical expenses offered by the government. With the current pace at which the treatment are developed in this location, North America is projected to record over 9.5% CAGR during 2018 to 2026.

Cushing’s Syndrome and Acromegaly Treatment Market: Summary of the report

This comprehensive report highlights the key trends that have impacted the Cushing’s Syndrome and Acromegaly Treatment market. The market size has been provided in terms of value (US$ Mn). An analysis is carried out to estimate the attractiveness of the Cushing’s syndrome and Acromegaly Treatment market depending on the drug type, distribution channels, and country. A brand share analysis based on the trends of 2017 is present in the study. The study highlights opportunities and threats of the existing market in order to aid independent healthcare devise better strategies with the help of impact analysis.

The report encompasses of the top competitive players in the market that can help the new entrants in this arena to make strategic decisions. The significant players in the market consists of Corcept Therapeutics, Bristol-Myers Squibb Company, HRA Pharma, Pfizer Inc., Ipsen Biopharmaceuticals, Inc., Novartis AG, among the rest. This insightful report consists of a brief study for each of these companies in order to help the newbies understand the historical and current strategies that are followed in the market.

The regional split for the market, as per the report consists of – North America, Latin America, Western Europe and Asia Pacific. While North America dominates the market by the contribution of U.S., Europe and Asia Pacific are catching up the pace and a CAGR of over 8% and 10% is expected for these locations respectively. China, running at the top speed in terms of healthcare and economy is projected to make a notable shift in Asia Pacific.

Browse Full Global Cushing’s Syndrome and Acromegaly Treatment Market Report with

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords. 

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.


State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States

Telephone: +1-518-730-0559